2023 Annual Meeting | C197 - Specialty Population Sleep Disorders

Date Thursday 04/27/23

Time 01:00 PM - 03:00 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Joyce K. Lee-Iannotti, MD, FAAN

Topic(s) Sleep

Learning Objectives Participants will get a review of specific sleep disorders and issues within speciality populations, including patients with refractory insomnia, women, and patients with neurotrauma.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Program Tracks Diversity, Equity, and Inclusion

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
01:00 PM - 01:05 PM EST	Speaker	Introduction to Course Joyce K. Lee-Iannotti, MD, FAAN
01:05 PM - 01:40 PM EST	Speaker	Sleep and Neurotrauma J. Kent Werner, Jr., MD, PhD
01:40 PM - 02:20 PM EST	Speaker	Sleep in Women Annise G. Wilson, MD
02:20 PM - 03:00 PM EST	Speaker	Sleep Neuromodulation for Insomnia: Are We There Yet? Brynn K. Dredla, MD

Faculty Disclosures
Joyce K. Lee-Iannotti, MD, FAAN	Dr. Lee-Iannotti has nothing to disclose.
J. Kent Werner, Jr., MD, PhD	Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has stock in Cogentis Therapeutics. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics.
Annise G. Wilson, MD	Dr. Wilson has nothing to disclose.
Brynn K. Dredla, MD	The institution of Dr. Dredla has received research support from NIH.